Syneos Health SYNH recently entered into a definitive agreement to be acquired by a private investment consortium in an all-cash transaction of approximately $7.1 billion. The consortium of private ...

Syneos Health stockholders approved the firm’s $7.1 billion sale to a consortium of private equity firms, the company said after a special meeting Wednesday. The group taking Syneos private consists ...

Syneos Health inked a multiyear deal with Microsoft to further develop a platform that leverages machine learning to support and speed the analysis, design and operations of clinical trials and ...

Syneos Health has officially gone private, the company announced Thursday morning. The 2023 MM+M Agency 100 honoree completed the $7.1 billion all-cash transaction with a cohort of private equity ...

Syneos Health, a leading biopharmaceutical contract research organization, agreed to be acquired for $7.1 billion by a group of private equity firms. Elliott Investment Management, Patient Square ...

All the rumors are true. After months of sale speculation, Syneos Health has officially been snapped up by three private investment firm affiliates for the eye-watering sum of $7.1 billion. The North ...

Syneos Health, Inc. SYNH is well-poised for growth in the coming quarters, backed by strategic partnership deals and contributions from the Syneos One portfolio. The company’s Clinical Solutions arm ...

Elligo Health Research has announced it is expanding its IntElligo Study Marketplace platform with Syneos Health. The platform aims to make sales, site selection and application processes more ...

MORRISVILLE – Syneos Health is now a private company, having wrapped up its deal valued at some $7 billion with private equity partners Elliott Investment Management L.P., Patient Square Capital and ...

Syneos Health Inc.’s stock SYNH soared 9% in premarket trade Wednesday, after the biopharma services company said it has agreed to be acquired by a private investment consortium for about $7.1 billion ...

March 9 (Reuters) - Syneos Health Inc SYNH.O, a U.S. contract research organization (CRO) that serves the pharmaceutical industry, is exploring a sale, people familiar with the matter said on Monday.

MORRISVILLE – Syneos Health (Nasdaq:SYNH) has bought RxDataScience in another deal to expand its service offerings. It’s the second acquisition that Syneos has made in the prior four weeks. In ...